-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Globus Medical, Raises Price Target to $100

Benzinga·12/17/2025 13:15:17
语音播报
RBC Capital analyst Shagun Singh maintains Globus Medical (NYSE:GMED) with a Outperform and raises the price target from $92 to $100.